Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Inventory Average of $994.0 for Q3 2025, down 70.71% year-over-year from $3394.0 in Q3 2024, and little changed quarter-over-quarter from $994.0 in Q2 2025.
Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Inventory Average for 5 consecutive years, with $994.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Inventory Average fell 70.71% year-over-year to $994.0; the TTM figure through Sep 2025 stood at $994.0 (down 70.71% YoY), while the FY2024 annual figure was $4394.0, down 47.65% from the prior year.
- Inventory Average steadied at $994.0 in Q3 2025 per CELZ's latest filing, from $994.0 in the prior quarter.
- Across five years, Inventory Average topped out at $18259.5 in Q3 2022 and bottomed at $994.0 in Q2 2025.
- Historically, Inventory Average has averaged $7942.2 across 4 years, with a median of $7194.0 in 2023.
- Annual changes were most pronounced in 2023 — Inventory Average slipped 18.5% — and 2025, when it tumbled 80.1%.
- Creative Medical Technology Holdings' Inventory Average stood at $13044.0 in 2022, then sank by 44.85% to $7194.0 in 2023, then tumbled by 61.16% to $2794.0 in 2024, then tumbled by 64.42% to $994.0 in 2025.
- Business Quant data shows CELZ's Inventory Average at $994.0 in Q3 2025, $994.0 in Q2 2025, and $1594.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Sep 30, 2025 | 994.00 |
| Jun 30, 2025 | 994.00 |
| Mar 31, 2025 | 1,594.00 |
| Dec 31, 2024 | 2,794.00 |
| Sep 30, 2024 | 3,394.00 |
| Jun 30, 2024 | 4,994.00 |
| Mar 31, 2024 | 6,594.00 |
| Dec 31, 2023 | 7,194.00 |
| Sep 30, 2023 | 8,994.00 |
| Jun 30, 2023 | 10,194.00 |
| Mar 31, 2023 | 10,194.00 |
| Dec 31, 2022 | 13,044.00 |
| Sep 30, 2022 | 18,259.50 |
| Jun 30, 2022 | 17,387.50 |
| Mar 31, 2022 | 12,508.00 |
| Jun 30, 2020 | 2,000.00 |